Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
J
|
JHM Consolidation Bhd
KLSE:JHM
|
MY |
|
Check Cap Ltd
NASDAQ:CHEK
|
IL |
|
S
|
South Jersey Industries Inc
F:J4S
|
US |
Wall Street
Price Targets
BMRN Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for
BMRN
is 91.69 USD
with a low forecast of 55.55 USD and a high forecast of 126 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BMRN's stock price target?
Price Target
91.69
USD
According to Wall Street analysts, the average 1-year price target for
BMRN
is 91.69 USD
with a low forecast of 55.55 USD and a high forecast of 126 USD.
What is Biomarin Pharmaceutical Inc's Revenue forecast?
Projected CAGR
12%
For the last 14 years the
compound annual growth rate for
Biomarin Pharmaceutical Inc's revenue is
15%.
The projected
CAGR
for the next 3 years is
12%.
What is Biomarin Pharmaceutical Inc's Operating Income forecast?
Projected CAGR
24%
The
compound annual growth rate
of Biomarin Pharmaceutical Inc's operating income for the next 3 years is
24%.
What is Biomarin Pharmaceutical Inc's Net Income forecast?
Projected CAGR
58%
The
compound annual growth rate
of Biomarin Pharmaceutical Inc's net income for the next 3 years is
58%.
